: Developmental Funds have continued to play a key role in the global reorganization of the Cancer Center that was initiated during the last CCSG budget period. Supported by a thorough, transparent and inclusive strategic planning process, the Cancer Center has undergone major changes in its administrative infrastructure, refinement of scientific and educational objectives, expansion of programmatic themes and global realignment of Shared Resources. A pivotal aspect of this reorganization was a focused and thematic faculty recruitment effort that led to the hiring of nine new Cancer Center members at all academic ranks and appointed across the three scientific Programs during the last budget period. Judiciously deployed as part of a flexible, inclusive and goal-oriented decision-making process, CCSG Developmental Funds have been instrumental to enable the long-range directives ofthe 2012 Cancer Center Strategic Plan, contributing to new faculty recruitment, facilitating inter-programmatic and collaborative pilot projects, supporting the launch of a new developmental Translational Research Management core, and expanding the collection of clinically annotated primary tumor samples for molecular validation studies, prognostic biomarker assessment and identification of new cancer targets. In this context, CCSG Developmental Funds have tangibly contributed to the sharp upward trajectory of the Cancer Center of the last budget period, reflected in significantly increased cancer focus, growth in NCI and cancer-related funding, expansion of inter- and intraprogrammatic collaborative publications, and launch of a portfolio of scientific initiatives along the continuum of basic, translational and patient-oriented cancer research. Building on these validated principles, CCSG Developmental Funds will continue to support the upward trajectory of the Cancer Center over the next budget period, supporting new faculty recruitment and expanding the Center-wide tools that have been put in place to enable translational and patient-oriented cancer research across all three scientific Programs.

Public Health Relevance

CCSG Developmental Funds have provided a critical asset to enable the transformative changes introduced in the Cancer Center during the last CCSG budget period, especially in the areas of new faculty recruitment and translational cancer research. A detailed plan has been formulated to build on these accomplishments and continue on the trajectory of growth of the cancer research agenda ahead of the upcoming faculty and facility expansion

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Wistar Institute
United States
Zip Code
Qin, Jie; Rajaratnam, Rajathees; Feng, Li et al. (2015) Development of organometallic S6K1 inhibitors. J Med Chem 58:305-14
Tomescu, Costin; Seaton, Kelly E; Smith, Peter et al. (2015) Innate activation of MDC and NK cells in high-risk HIV-1-exposed seronegative IV-drug users who share needles when compared with low-risk nonsharing IV-drug user controls. J Acquir Immune Defic Syndr 68:264-73
Gekonge, Bethsebah; Bardin, Matthew C; Montaner, Luis J (2015) Short communication: Nitazoxanide inhibits HIV viral replication in monocyte-derived macrophages. AIDS Res Hum Retroviruses 31:237-41
Webster, Marie R; Xu, Mai; Kinzler, Kathryn A et al. (2015) Wnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cells. Pigment Cell Melanoma Res 28:184-95
Zhang, Xuhui; Akech, Jacqueline; Browne, Gillian et al. (2015) Runx2-Smad signaling impacts the progression of tumor-induced bone disease. Int J Cancer 136:1321-32
Kung, Che-Pei; Khaku, Sakina; Jennis, Matthew et al. (2015) Identification of TRIML2, a novel p53 target, that enhances p53 SUMOylation and regulates the transactivation of proapoptotic genes. Mol Cancer Res 13:250-62
Gumireddy, Kiranmai; Li, Anping; Kossenkov, Andrew V et al. (2014) ID1 promotes breast cancer metastasis by S100A9 regulation. Mol Cancer Res 12:1334-43
Wolf, Amaya I; Strauman, Maura C; Mozdzanowska, Krystyna et al. (2014) Pneumolysin expression by streptococcus pneumoniae protects colonized mice from influenza virus-induced disease. Virology 462-463:254-65
Newhart, Alyshia; Janicki, Susan M (2014) Seeing is believing: visualizing transcriptional dynamics in single cells. J Cell Physiol 229:259-65
Budina-Kolomets, Anna; Balaburski, Gregor M; Bondar, Anastasia et al. (2014) Comparison of the activity of three different HSP70 inhibitors on apoptosis, cell cycle arrest, autophagy inhibition, and HSP90 inhibition. Cancer Biol Ther 15:194-9

Showing the most recent 10 out of 182 publications